Skip to main content

Table 4 Comparison of the sample distribution of each DV and predicted values following the reallocation of time from ST to MVPA

From: Compositional analysis of the associations between 24-h movement behaviours and cardio-metabolic risk factors in overweight and obese adults with pre-diabetes from the PREVIEW study: cross-sectional baseline analysis

Minutes reallocatedBMIWaistBody fatInsulinHOMA-IR2 h GlucoseTriglyceridesHDL-Chs-CRP
DPDPDPDPDPDPDPDPDP
10.0210.8710.0220.8470.0130.9950.00910.00810.01110.0170.9810.00810.0120.999
20.0340.3430.0310.4430.0230.8210.0130.9950.0120.9980.0160.9870.0270.6150.01110.0180.961
30.0440.1080.0440.0990.0270.6460.0170.9810.0170.9720.0210.8710.0370.2410.0120.9990.0240.765
40.0560.0160.0540.0230.0320.4160.0200.9140.0210.8930.0270.6450.0470.0630.0140.9980.0280.585
50.0650.0030.0640.0040.0380.2240.0230.7930.0240.7650.0290.5260.0530.0250.0170.9810.0340.321
60.0760.0010.0730.0010.0420.1400.0250.7060.0270.6150.0330.3660.0610.0060.0180.9610.0400.178
7    0.0470.0630.0280.5850.0300.4970.0360.2600.0680.0020.0180.9610.0420.128
8    0.0520.0310.0290.5260.0320.4160.0390.192  0.0200.9140.0470.063
9    0.0550.0180.0320.4160.0340.3430.0420.128  0.0210.8710.0520.031
10    0.0590.0090.0340.3430.0360.2790.0460.083  0.0230.7930.0550.018
11      0.0350.2990.0370.2410.0480.057  0.0260.6760.0590.009
12      0.0370.2410.0400.1780.0520.031  0.0290.555  
13      0.0380.2080.0410.1510.0550.018  0.0310.442  
14      0.0400.1640.0430.1180.0580.010  0.0320.416  
15      0.0420.1390.0460.083    0.0340.343  
16      0.0440.0990.0480.057    0.0340.321  
17      0.0460.0830.0500.052    0.0350.299  
18      0.0470.0630.0530.025    0.0360.279  
19      0.0490.0520.0550.018    0.0370.241  
20      0.0490.047      0.0380.208  
  1. Two sample Kolmogorov-Smirnov test comparing the sample distribution between predicted value of each dependant variable and the predicted value with the sequential reallocation of 1 min from ST to MVPA
  2. ST sedentary time, MVPA moderate-to-vigorous physical activity, BMI body mass index, HOMA-IR homeostasis model assessment for insulin resistance, HDL-C high density lipoprotein cholesterol, hs-CRP high sensitivity C-reactive protein